University Of California, San Francisco

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Sertraline in Addition to Standard of Care Treatment for Coccidioidomycosis

Phase 2

Withdrawn

Conditions: Coccidioidomycosis

Interventions: Drug: Sertraline

First Posted Date: 2016-09-20

Last Posted Date: 2022-03-21

Lead Sponsor: University of California, San Francisco

Registration Number: NCT02908334

Integrative Approaches for Cancer Survivorship 2: Project 2

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Behavioral: Individualized Manualized Health Education Intervention

First Posted Date: 2016-09-13

Last Posted Date: 2019-03-05

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 20

Registration Number: NCT02897544

Locations: 🇺🇸
University of California, San Francisco, Osher Center for Integrative Medicine, San Francisco, California, United States

Integrative Approaches For Cancer Survivorship 2: Project 1

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Behavioral: Individualized Integrative Medicine Intervention

First Posted Date: 2016-09-13

Last Posted Date: 2019-03-05

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 20

Registration Number: NCT02897635

Locations: 🇺🇸
University of California, San Francisco, Osher Center for Integrative Medicine, San Francisco, California, United States

Innovative Behavioral Economics Incentives Strategies for Health

Not Applicable

Completed

Conditions: HIV/AIDS

Interventions: Other: Prize incentive - Low
Behavioral: Fixed Incentive - Voucher
Behavioral: Loss Aversion - Deposit
Other: Escalating payment incentive
Other: Travel Voucher
Other: Prize incentive - High
Other: Standard care
Behavioral: Fixed Incentive - Prize
Behavioral: Loss Aversion - Prize
Behavioral: Lottery - Prize

First Posted Date: 2016-09-07

Last Posted Date: 2022-02-24

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 3580

Registration Number: NCT02890459

Locations: 🇺🇬
Infectious Diseases Research Collaboration, Mbarara, Uganda

School-Home Program for Mexican Children With Attention and Behavioral Concerns

Not Applicable

Completed

Conditions: ADHD

Interventions: Behavioral: CLS-FUERTE

First Posted Date: 2016-09-05

Last Posted Date: 2021-10-14

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 58

Registration Number: NCT02888821

Oxytocin HIV Meth Study

Phase 1

Completed

Conditions: Amphetamine Use Disorders

Interventions: Drug: Oxytocin
Drug: Placebo

First Posted Date: 2016-08-26

Last Posted Date: 2019-03-05

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 48

Registration Number: NCT02881177

Locations: 🇺🇸
University of California, San Francisco, San Francisco, California, United States

Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of AK on the Face in Solid Organ Transplant Recipients

Phase 4

Completed

Conditions: Actinic Keratosis

Interventions: Drug: ingenol mebutate gel 0.015%

First Posted Date: 2016-08-15

Last Posted Date: 2022-03-09

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 20

Registration Number: NCT02866695

Locations: 🇺🇸
UCSF Dermatology, San Francisco, California, United States

CRUSH-PrEP for Women Project

Not Applicable

Completed

Conditions: Sexually Transmitted Diseases
HIV

Interventions: Other: Pre Exposure Prophylaxis
Behavioral: Characteristics of women who enroll
Behavioral: referral sources of women who enroll

First Posted Date: 2016-08-02

Last Posted Date: 2019-09-11

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 30

Registration Number: NCT02852226

Locations: 🇺🇸
Lifelong Medical Care, Oakland, California, United States

Health-E You: Reducing Unintended Pregnancies Among Hispanic Adolescents

Not Applicable

Completed

Conditions: Unprotected Sex
Unsafe Sex

First Posted Date: 2016-07-28

Last Posted Date: 2019-10-23

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 1360

Registration Number: NCT02847858

Locations: 🇺🇸
Carson Wellness Center, Los Angeles, California, United States
🇺🇸
Belmont Wellness Center, Los Angeles, California, United States

Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy?

Not Applicable

Completed

Conditions: Type 2 Diabetes Mellitus

Interventions: Drug: GLP1 receptor agonist
Drug: basal insulin
Drug: SGLT2 inhibitor
Drug: Metformin

First Posted Date: 2016-07-27

Last Posted Date: 2020-11-10

Lead Sponsor: University of California, San Francisco

Target Recruit Count: 22

Registration Number: NCT02846233

Locations: 🇺🇸
UCSF Fresno, Fresno, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy